CALGB-49907
|
CALGB
|
A Randomized Trial of Adjuvant Chemotherapy with Standard Regimens; Cyclophosphamide; Methotrexate and Fluorouracil - (CMF) or Doxorubicin and Cyclophosphamide - (AC); Versus Capecitabine in Women 65 Years and Older with Node Positive or Node Negative Breast Cancer
|
Adult CIRB - Late Phase Emphasis
|
Completed
|
|
CALGB-50303
|
CALGB
|
Phase III Randomized Study of R-CHOP v. Dose-Adjusted EPOCH-R with Molecular Profiling in Untreated De Novo Diffuse Large B-Cell Lymphomas
|
Adult CIRB - Late Phase Emphasis
|
Completed
|
|
CALGB-70301
|
CALGB
|
Quality of Life; Employment; and Informal Care Cost Analysis in Women Receiving Adjuvant Chemotherapy for Breast Cancer with 0-3 Positive Axillary Lymph Nodes: Companion to CALGB 40101
|
Adult CIRB - Late Phase Emphasis
|
Completed
|
|
CALGB-80101
|
CALGB
|
Phase III Intergroup Trial of Adjuvant Chemoradiation After Resection of Gastric or Gastroesophageal Adenocarcinoma
|
Adult CIRB - Late Phase Emphasis
|
Completed
|
|
CALGB-80203
|
CALGB
|
A Phase III Trial of Irinotecan/5-FU/Leucovorin or Oxaliplatin/5-FU/Leucovorin with and without Cetuximab (C225) for Patients with Untreated Metastatic Adenocarcinoma of the Colon or Rectum
|
Adult CIRB - Late Phase Emphasis
|
Completed
|
|
CALGB-80303
|
CALGB
|
A Randomized Phase III Trial of Gemcitabine Plus Bevacizumab (NSC #704865 IND# 7921) Versus Gemcitabine Plus Placebo in Patients with Advanced Pancreatic Cancer
|
Adult CIRB - Late Phase Emphasis
|
Completed
|
|
CALGB-80702
|
CALGB
|
A Phase III Trial of 6 Versus 12 Treatments of Adjuvant FOLFOX Plus Celecoxib or Placebo for Patients with Resected Stage III Colon Cancer
|
Adult CIRB - Late Phase Emphasis
|
Available to Open
|
|
CALGB-80802
|
CALGB
|
Phase III Randomized Study of Sorafenib Plus Doxorubicin Versus Sorafenib in Patients with Advanced Hepatocellular Carcinoma (HCC)
|
Adult CIRB - Late Phase Emphasis
|
Available to Open
|
|
CALGB-90104
|
CALGB
|
A Randomized Phase III Study Comparing Sequential Chemotherapy (AG-TP) to Cisplatin and Gemcitabine as Adjuvant Treatment After Cystectomy for Transitional Cell Carcinoma of the Bladder
|
Adult CIRB - Late Phase Emphasis
|
Completed
|
|
CALGB-90106
|
CALGB
|
A Randomized Phase III Study of Paclitaxel; Ifosfamide and Cisplatin Versus Vinblastine; Ifosfamide and Cisplatin as Second-Line Therapy for Patients with Relapsed/Resistant Germ Cell Tumors
|
Adult CIRB - Late Phase Emphasis
|
Completed
|
|